GlassScriptPhysician profile
Pei-Chi Fu
NPI 1053363473
$2,055.26
in general payments reported to CMS, 2019-2025
20 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $317 · 2021: $125 · 2022: $120 · 2023: $340 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $453.00 | 2019-2023 | Saphnelo, Farxiga |
| Pfizer INC. | $261.91 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $194.99 | 2019-2021 | |
| Lilly USA, LLC | $190.84 | 2019 | |
| Novo Nordisk INC | $189.34 | 2019-2021 | |
| Incyte Corporation | $124.17 | 2023 | Opzelura |
| Genzyme Corporation | $120.76 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.20 | 2019-2020 | |
| Glaxosmithkline, LLC. | $63.54 | 2019-2020 | |
| Intuitive Surgical, INC. | $61.70 | 2023 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $57.48 | 2019-2022 | |
| Amgen INC. | $57.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $48.94 | 2019-2020 | |
| Abbvie INC. | $36.14 | 2019 | |
| Daiichi Sankyo INC. | $27.25 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $19.11 | 2023 | Dexcom G6 Transmitter |
| Roche Diabetes Care, INC. | $13.98 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.44 | 2021 | |
| Pulmonx Corporation | $13.26 | 2019 | |
| Circassia INC. | $12.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pei-Chi Fu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.